Date: 2026-04-08 Market cap: ~$1.0B | EV/TTM Rev: ~1.23x | Revenue growth: +26% FY YoY (Q4 19.8%) Stock price: $12.22 | 52-week range: 8.61–44.99 Source: Scout brief PGY_stock-analysis_2026-04-08, stages/scuttlebutt, stages/quant-prep, stages/transcript-digests
PGY fails the Gate on two hard criteria (revenue growth 19.8% YoY vs >30%; gross margin 40.8% vs >60%) and remains outside the core growth portfolio universe. But this is now a deep value transition story that demands attention: at $12.22 the stock trades at 0.78x TTM P/S, 3.7x non-GAAP P/E, and 4.5x P/FCF — pricing that implies the business is in terminal decline rather than growing 15%+ and generating $225M in annual FCF. The auto resecuritization (RPM 2026-R1, March 2026) is the strongest counter-evidence yet against the Iceberg Research bear thesis — KBRA ratings on seasoned 2023-2024 vintage loans prove those cohorts performed well enough for institutional repurchase. Operating leverage is structurally real. Credit quality is the single variable that determines whether this is a 3-4x re-rating opportunity or a value trap. Conviction: 2.5/5 (up from 2/5 in February). The auto resecuritization, five oversubscribed Q1 ABS deals, and further price compression warrant modest conviction increase, but Iceberg silence and macro headwinds from tariff-driven consumer stress keep this below 3.
| Criterion | Threshold | Actual | Pass/Fail |
|---|---|---|---|
| Revenue YoY growth | >30% | 19.8% (Q4); 26% FY | FAIL |
| Gross margin | >60% | 40.8% | FAIL |
| Revenue per quarter | >$50M | $334.8M | Pass |
| Data availability | 4+ quarters | 13 quarters in DB | Pass |
| Share dilution | <10% annual | ~7.9% basic YoY | Pass |
| GAAP profitability trajectory | Improving | 4 consecutive GAAP profitable quarters; first profitable FY ($81M) | Pass |
Gate: FAIL. Two hard fails. Full analysis provided because the valuation compression since February has brought this into deep-value territory warranting detailed assessment.
| Factor | Rating | Detail |
|---|---|---|
| Growth | Weak | +19.8% YoY in Q4 (down from 36.2% in Q3). FY25 +26% YoY. FY26 guided 14% midpoint. Long-term target 15-20%. |
| Trajectory | Decelerating | Q1: 18% → Q2: 30% → Q3: 36% → Q4: 20%. Sharpest single-quarter deceleration in 13-quarter history (-16.4pp). First QoQ sequential decline ever (-4.3%). FY26 guide confirms structural step-down. |
| Margins | Low (improving) | GM 40.8% (fails 60% floor). But OpM 24.8% GAAP is an all-time high (+13.3pp YoY). Adj EBITDA 29.3% margin. FCF 22.9% margin. Core OpEx at 36% of FRLPC (down from 49% YoY). Incremental EBITDA margin >100%. |
| Dominance | Strong | Embedded via API in lender workflows (31 partners, 130+ ABS investors). Multi-product stickiness: partners on 2+ products = 30% of lenders but 67% of volume. Auto resecuritization template creates capital markets moat competitors cannot replicate without multi-year ABS track record. No at-scale B2B-only AI underwriting competitor. |
| Valuation | Very Cheap | 0.78x P/S. 1.23x EV/TTM Rev. 3.7x non-GAAP P/E. 4.5x P/FCF. 4.3x EV/EBITDA. PEG 0.04x. Rule of 40: 42.7. Priced as distressed financial, performing as profitable growth company. |
| Special | Present | Post-washout (-72% from 52-week high). Auto resecuritization proving vintages. Five Q1 2026 ABS deals all oversubscribed. $225M FY25 FCF. Tariff-driven macro uncertainty creating additional fear discount. Q1 results May 7 as near-term catalyst. |
| Quarter | Calendar | Revenue ($M) | QoQ % | YoY % | Gross Margin | Op Margin | Net Margin | Adj EBITDA Margin | FCF ($M) |
|---|---|---|---|---|---|---|---|---|---|
| Q2_FY22 | Jun-22 | 163.3 | — | — | 35.7% | -92.2% | -107.3% | — | — |
| Q1_FY23 | Mar-23 | 186.6 | +14.3% | — | 28.6% | -14.3% | -34.8% | — | -29.2 |
| Q2_FY23 | Jun-23 | 195.6 | +4.8% | +19.8% | 35.1% | -5.5% | -16.9% | — | — |
| Q3_FY23 | Sep-23 | 211.8 | +8.3% | — | 36.0% | +0.1% | -10.8% | 13.4% | — |
| Q4_FY23 | Dec-23 | 218.0 | +2.9% | — | 36.1% | +5.1% | -6.6% | 15.7% | 14.3 |
| Q1_FY24 | Mar-24 | 245.0 | +12.4% | +31.3% | 38.9% | +3.2% | -8.9% | 16.2% | 12.6 |
| Q2_FY24 | Jun-24 | 250.0 | +2.0% | +27.8% | 40.0% | +2.1% | -30.8% | 20.1% | 4.9 |
| Q3_FY24 | Sep-24 | 257.0 | +2.8% | +21.3% | 40.2% | +9.0% | -27.1% | 21.8% | 3.2 |
| Q4_FY24 | Dec-24 | 279.4 | +8.7% | +28.2% | 42.6% | +11.5% | -86.3%* | 23.0% | 42.7 |
| Q1_FY25 | Mar-25 | 290.0 | +3.8% | +18.4% | 40.9% | +16.9% | +2.8% | 27.4% | 30.6 |
| Q2_FY25 | Jun-25 | 326.0 | +12.4% | +30.4% | 39.7% | +17.8% | +5.3% | 26.4% | 53.6 |
| Q3_FY25 | Sep-25 | 350.0 | +7.4% | +36.2% | 41.0% | +23.5% | +6.6% | 30.6% | 63.8 |
| Q4_FY25 | Dec-25 | 334.8 | -4.3% | +19.8% | 40.8% | +24.8% | +10.2% | 29.3% | 76.7 |
*Q4_FY24 GAAP net loss -237.9Mdrivenby 270M non-cash FV adjustments. Operating income was +$31.7M.
Full-year FY25: Revenue $1,300.8M (+26% YoY). EBITDA $371M (+76%). GAAP NI 81M(vs−401M loss in FY24). FCF $224.7M (+647%).
PGY has completed the transition from loss-making SPAC to GAAP-profitable company generating $225M in annual FCF, yet trades at 0.78x P/S and 3.7x non-GAAP P/E — multiples that imply the business is dying. The market is applying both a growth penalty (20% to 15% deceleration) and an opacity/credit discount (Iceberg Research, ABS risk) simultaneously. The evidence suggests both are being double-counted.
Supporting evidence:
PGY is a leveraged financial company dressed as a tech platform. The 40.8% gross margin, $824M in debt, $945M in credit-risky assets on the balance sheet, and $107M annual impairments are the profile of a lending-adjacent business that deserves lending-sector multiples. The 1x P/S is appropriate.
Supporting evidence:
The auto resecuritization and five oversubscribed Q1 ABS deals tilt the evidence modestly toward the thesis since February. KBRA ratings are a credible third-party stamp that Iceberg cannot easily dismiss. But the anti-thesis remains powerful: management silence on Iceberg for 14 months, evasive answers on volume pullback, no insider buying, no buyback, and macro headwinds mounting. This remains a "show me" story where Q1 FY26 results (May 7) and the first half of FY26 credit performance data will be decisive.
FRLPC take rate (key indicator): 3.2% (Q4_FY23) to 4.5% (Q4_FY24) to 5.0% (Q3_FY25) to 4.9% (Q4_FY25). Plateauing at ~5%. With take rate stabilized, revenue growth must increasingly track volume growth. This makes partner onboarding velocity the critical variable for FY26 revenue trajectory. If FRLPC % compresses toward 4.5% in Q1/Q2 FY26, revenue deceleration will be worse than guided.
Volume divergence: Network volume grew +3.1% YoY in Q4 while revenue grew +19.8% YoY — entirely explained by take-rate expansion. With take rate plateauing, this divergence will narrow. Q1 FY26 volume guided $2.5-2.7B (flat to down from $2.68B in Q4). No bullish divergence visible.
Partner pipeline (forward-looking): 7-8 new partner onboardings committed by end of Q2 FY26 (Das, prepared remarks). Multiple large personal loan partners expected on prescreen by Q1 end. This is the volume recovery catalyst. If both deliver, H2 FY26 volume recovery is feasible. If either slips, guidance skews to low end ($1.4B = only +7.6% growth).
New product economics: Affiliate optimizer and prescreen cited as "substantially better economics." LendingClub on Credit Karma via affiliate optimizer. Experian Activate partnership signed. Top 5 partners on new products. FY26 is the first year these contribute materially. Watch FRLPC % in Q1/Q2 FY26 for validation.
Credit impairments — stable, not improving: $107M in FY25, guided $100-150M in FY26 (identical range). The auto resecuritization provides positive counter-evidence on vintage performance, but headline impairment guidance is unchanged. ABS spreads widened +25bps on AAA in November 2025.
Macro headwind (new since last analysis): April 2026 tariff regime adds ~$780-1,338 per household in consumer costs (Yale Budget Lab). Consumer credit stress rising. KBRA/S&P project auto ABS delinquency rates to weaken in 2026. This is a headwind for lending volumes and credit quality — the exact variables management was pre-emptively tightening against in Q4.
Sources: stages/scuttlebutt/PGY/2026-04-02.md + supplementary WebSearch April 8, 2026.
Capital markets health is the strongest positive signal. Five Q1 2026 ABS transactions all fully subscribed or upsized: $800M PAID 2026-1 (+33% upsize, 32 investors), $400M RPM 2026-1 auto (20+ investors, +62% YoY), $450M RPM 2026-R1 auto resecuritization (KBRA-rated, inaugural structure), 350MrevolvingABSwith26North( 700M capacity), $720M Sound Point POS forward flow. Pattern: institutional capital is deepening, not withdrawing. [BusinessWire, Pagaya IR, StockTitan, The Next Web]
Auto resecuritization (RPM 2026-R1) is the most strategically significant deal. Bundles 2023-2024 vintage receivables. KBRA assigned preliminary ratings to six note classes. The deal cannot exist if the underlying loans are non-performing. This is the strongest counter-evidence to Iceberg Research to date. [The Next Web, StockTitan]
Iceberg Research covered its short (May 2025) and has published nothing new. Class action investigations from four law firms remain active but no formal lawsuit filed. Management still has not publicly answered the Iceberg questions. [Iceberg Research blog, PRNewswire]
Analyst consensus: 8 analysts, average "Strong Buy," $34.50 PT = 182% upside. Market deeply skeptical. Benchmark lowered PT to $33 from $48 post-Q4. Jefferies $30 PT. Multiple SA Strong Buy articles in March-April 2026 (GARP at 4x P/E, Hidden Value, Deep Value). [SA, MarketBeat, StockTwits]
CFO insider selling (routine). Perros sold $147K at $11.34 (April 1) and $92K at $10.99 (March 12), both post-RSU vesting. January: executive sold $1.7M. No insider purchases. No buyback program. [Investing.com, Motley Fool]
Glassdoor: 3.3/5 from 218 reviews (marginally improved from 3.2/215). 52% recommend (up 1pp). Culture themes unchanged: management quality concerns, high turnover, "toxic" references persist. 5-7 open positions (down from ~12 in February). [Glassdoor]
Tariff-driven macro pressure. Yale Budget Lab estimates $780-1,338 per-household consumer cost increase from April 2026 tariffs. Adds headwind to consumer lending volumes and credit quality. Consistent with management's "proactive" credit tightening narrative but could push actual results toward low end of FY26 guidance. [Yale Budget Lab]
| Metric | Current (Apr-2026) | At Q4 ER (Feb-2026) | Peer: UPST | Assessment |
|---|---|---|---|---|
| Market Cap | ~$1.0B | ~$1.5B | ~$4.5B | Compressed 33% since ER |
| EV | ~$1.6B | ~$2.0B | — | |
| P/S (TTM) | 0.78x | 1.15x | ~5-6x | Extremely cheap |
| EV/TTM Revenue | 1.23x | 1.57x | ~8-10x | Extremely cheap |
| EV/TTM Gross Profit | 3.1x | 3.9x | ~15x | Cheap |
| P/E GAAP (TTM) | 12.5x | 18.5x | >100x | Cheap |
| P/E Non-GAAP (TTM) | 3.7x | 5.5x | ~30x | Extremely cheap |
| P/FCF (TTM) | 4.5x | 6.7x | — | Compelling if FCF sustains |
| EV/EBITDA (Adj) | 4.3x | 5.4x | ~25x | Very cheap |
| PEG | 0.04x | 0.06x | — | Almost zero growth premium |
| Rule of 40 | 42.7 (FY) | 42.7 | — | Elite tier |
EV calculation: $1.01B market cap + $824M total debt - 288Mtotalcash= 1.55B.
Key observation: Every valuation metric has compressed 25-40% since the February earnings report despite no new negative fundamental data. The stock is down from ~$14 to $12.22 (-13%) while five oversubscribed ABS deals and the auto resecuritization have provided incremental positive evidence on credit quality. The disconnect between fundamental progress and stock price action reflects macro fear (tariffs, consumer credit cycle concern), continued Iceberg overhang, and small-cap fintech being out of favour.
Relative valuation matters: At 3.7x non-GAAP P/E growing 15-20% with a Rule of 40 score of 42.7, PGY is priced as a distressed financial institution. Fintech peers trade at 15-30x earnings. Even at 8x non-GAAP P/E (a third of fintech median), the stock would be ~$27 — 120% upside. The market is pricing either (a) a credit event that wipes out profitability or (b) permanent opacity discount. The auto resecuritization weakens the evidence for (a).
PGY occupies a defensible niche: AI underwriting for applicants that traditional credit scoring systematically rejects, embedded in lender workflows via API. The secular tailwind is real — static bureau models (FICO) misprice credit risk for ~30-40% of U.S. consumers, and AI-driven underwriting at scale has genuine alpha potential in identifying creditworthy borrowers within that pool.
This is not a true platform (no marketplace, no demand-side network effects). It is B2B SaaS-adjacent infrastructure with switching costs from API integration, 18-month joint roadmaps, and committed fee/volume structures. The multi-product expansion (prescreen, affiliate optimizer, DualLook) creates genuine stickiness: 30% of partners on 2+ products = 67% of volume.
The auto resecuritization creates a capital markets moat: competitors without multi-year ABS track records and KBRA-rated performance history cannot replicate this structure. It took PGY 85+ ABS transactions to build the track record enabling resecuritization.
TAM: 238BinquarterlyU.S.consumerloanapplications.PGYprocesses 2.7B/quarter = ~1.1% penetration. Massive headroom, constrained by partner adoption velocity and credit model credibility.
Secular positioning (tariff era): Consumer credit tightening is simultaneously a headwind (lower volumes) and a validation mechanism (PGY's AI should outperform static models precisely during stress periods when conventional scoring fails). If AI underwriting demonstrably produces better credit outcomes during macro stress, PGY's value proposition to lenders strengthens. Q1-Q2 FY26 performance data will be the test.
Credit cycle deterioration remains the existential risk. If credit-related impairments ($107M in FY25, guided $100-150M in FY26) are the structural cost of a broken underwriting model rather than normalized reserves, the entire non-GAAP profitability narrative collapses. The auto resecuritization is counter-evidence but not conclusive — it proves 2023-2024 auto vintages performed, not that future personal loan vintages will. Tariff-driven consumer stress adds macro pressure PGY has no control over.
Iceberg Research unaddressed for 14 months. The specific allegation — that PGY uses managed funds to absorb toxic ABS tranches, masking true credit exposure — has never received a substantive management rebuttal. Four securities fraud investigations remain active. The silence is a red flag regardless of whether the allegation is accurate. A formal lawsuit would be a material negative event.
Management quality and transparency concerns. Glassdoor 3.3/5, 52% recommend. Evasive on volume pullback location ("primarily across entire portfolio"). No buyback despite 3.7x P/E and $235M cash. No insider purchases. The absence of capital return when the stock is this cheap is itself a signal.
Balance sheet leverage in adverse scenario. Net debt ~$536M against $81M GAAP NI. $945M investment portfolio carries mark-to-market risk through P&L. $148.8M in exchangeable notes plus $481.6M long-term debt require continued ABS market access. If ABS markets freeze, the model faces funding stress before revenue stress.
FY26 guidance may be optimistic given tariff macro. Wide range (1.4 − 1.575B)assumescurrentmacro.April2026tariffsadd 780-1,338 per household in consumer costs (Yale Budget Lab). Consumer credit stress is a real headwind for lending volumes. Partner behaviour already shifted from growth to caution by year-end 2025, before the tariff shock.
Q1 FY26 earnings (May 7, 2026). Partner onboarding scorecard (7-8 by Q2 end). Revenue at or above $325M guide midpoint. FRLPC % holding at 4.8%+. Credit impairment trending toward low end of $100-150M range. Any positive surprise would be a re-rating event given current depressed expectations.
ABS credit performance data (Q1-Q2 FY26). If Bloomberg/Moody's ABS data confirms personal loan CNLs 30-40% better than 2021 peak and auto CNLs holding through H1 FY26, the Iceberg overhang fades materially and the opacity discount compresses. The auto resecuritization is a start; ongoing data is the confirmation.
Capital return announcement. A buyback at 3.7x non-GAAP P/E would be maximally accretive and signal management confidence. The company generates enough FCF ($225M FY25 annualized) to fund a meaningful program without impacting operations. The absence of any buyback discussion remains a question mark.
Securities fraud investigation resolution. Clearance from any of the four pending investigations, or a substantive management rebuttal of Iceberg's specific allegations (with third-party ABS audit), would be the single largest overhang removal.
Tariff uncertainty resolution. If tariff fears prove overblown or are partially rolled back, consumer lending volumes recover faster than guided, and PGY's wide guidance range ($175M spread) skews to the high end. Conversely, sustained tariff impact pushes results toward the low end.
Position disclosure: No position in PGY.